The Liver Unit is made up of hepatologists who are committed to excellence in patient care and doing research that could someday, be useful in the clinic. This group of hepatologists have created a large and well developed General Hepatology Clinic that examines the areas of viral hepatitis, fatty liver disease, primary sclerosing cholangitis, liver transplantation and liver cancer. The Liver Unit serves a referral base of over 2 million people. It is a well-organized clinic with a large patient referral base, and streamlined approach to the care of patients with various forms of liver disease. This allows the Hepatology Group to attract a large number of clinical trials to Calgary, thereby providing our patients with the latest and most advanced therapeutic options for the treatment of liver disease.

The University of Calgary Liver Unit conducts research in both clinical trials and investigational projects:

Clinical trials are sponsored by drug companies and are used to evaluate the safety and effectiveness of investigational medications for treatment of various diseases. Current sponsored clinical trials with the Liver Unit include those involving patients with hepatitis B and C, liver cancer, non-alcoholic fatty liver disease, and autoimmune liver diseases. 

Investigational projects are developed and conducted locally by individual doctors at the Liver Unit and are useful for the advancement of understanding a disease and its outcome. These projects examine the general characteristics and trends of various liver diseases, and may include collection of biological samples and health information.

The Calgary Liver Unit collaborates with a number of national interest groups including:

Further information about the Calgary Liver Unit's research program can be found here

Referring Physicians